Pegvisomant

ATC H01AX01 · 6 markets · 29 records

Pegvisomant 6 markets · 29 records Forms
Filters

AU 7 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 20 mginjectionSOMAVERTSOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe also in GB·ES·FR unknown
  • 15 mginjectionSOMAVERTSOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe also in GB·ES·FR unknown
  • 10 mginjectionSOMAVERTSOMAVERT pegvisomant (rbe) 10mg powder for injection vial and diluent in pre-filled syringe also in GB·ES·FR unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

GB 5 records · 5 shown of 5 Source NHSBSA dm+d · Data as of 2026-10-19

CA 5 records · 5 shown of 5 Source Health Canada Drug Product Databas · Data as of 2026-10-23

ES 5 records · 5 shown of 5 Source CIMA (AEMPS) · Data as of live

FR 5 records · 5 shown of 5 Source Base de données publique des médic · Data as of 2026-11-03

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.